| Methods |
Cohort
Retrospective
Cross‐sectional. |
| Participants |
126 patients (77 men, 49 women), 75 APE, 51 AR.
Cohort of patients treated for rectal cancer between 1987 and 1999.
Inclusion criteria: Curative surgery for colorectal adenocarcinoma, no other primary malignant tumour, no additional complicating or disabling disease necessitating nursing help, minimum 1 year since surgery, no chemoradiotherapy within the previous four month, no admittance to hospital during study period, no clinical evidence of tumour recurrence.
Turkey. |
| Interventions |
Quality of life assessment with SF‐36. |
| Outcomes |
Quality of life. |
| Notes |
Evidence level 2B.
Not stated: Tumour distance from anal verge (APE), pouch AR group, radio/chemotherapy. |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
High risk |
Retrospective, cross‐sectional cohort study. Rectal cancer patients who had undergone surgery and meet predefined inclusion criteria were invited to participate. Not all eligible patients responded to questionnaire. |
| Blinding (performance bias and detection bias)
Anterior resection or abdominoperineal resection |
High risk |
Blinding not possible due to surgical therapy. |
| Incomplete outcome data (attrition bias)
Quality of life |
Low risk |
All included patients completed the study. |
| Selective reporting (reporting bias) |
Low risk |
All QoL data reported. |
